Vaccination of Melanoma Patients With Total or CD25-depleted Peripheral Blood Mononuclear Cell (PBMC)

NCT00961376 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped PI Discretion

Conditions

Melanoma

Interventions

BIOLOGICAL: PBMC re-infusion
BIOLOGICAL: CD25 depletion

Sponsor

Providence Health & Services